We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




MEDICA 2024 to Highlight Hot Topics of MedTech Industry

By LabMedica International staff writers
Posted on 08 Nov 2024

Once again this year, everything at MEDICA (Düsseldorf, Germany) will revolve around the major trends and challenges in medical technology. More...

The focus will be on four key topics that will have a lasting impact on the industry: Artificial Intelligence & Big Data, Robotics & Assistive Systems, Connected Care, and Skills Shortage & Staff Development.

The integration of artificial intelligence (AI) and big data into medical technology is revolutionizing healthcare. From precise diagnostics and personalized treatment plans to accelerated drug research – AI and big data are opening doors to new possibilities. At MEDICA 2024, visitors will have the chance to experience exciting solutions and research approaches that raise the efficiency and accuracy of medical procedures to a new level. Experts will present how these technologies support precise navigation during surgical procedures or optimize diagnoses by analyzing large amounts of data. Robotics and assistive systems are changing the way medical treatments are performed. At MEDICA 2024, attendees will experience how surgical robots make minimally invasive procedures more precise and rehabilitation robots speed up the recovery process. These technologies not only offer enormous added value for patients but also relieve the burden on medical staff. Visitors will be inspired by the latest developments that take efficiency and patient safety in the healthcare industry to a new level.

In an increasingly digitalized world, connected care plays a key role in medical technology. The combination of medical devices, digital platforms, and real-time data enables optimized patient care. At MEDICA 2024, everything revolves around connected solutions that enable precise diagnoses and treatments through wearables and implants. Connected care not only offers new possibilities for the treatment of patients but also supports medical professionals in making decisions more efficiently. The shortage of skilled workers poses considerable challenges for the medical technology industry. At MEDICA 2024, visitors will find out how companies are tackling this problem with innovative approaches to personnel development. Training programs, further education offers, and strategic personnel planning are crucial for attracting qualified specialists and retaining them in the long term. Attendees can learn from leading experts how targeted measures can secure the future of medical technology and what the current trends are in the field of personnel development.

Related Links:
MEDICA


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.